Pulse Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$42,210,000 over the previous period. Total operating expenses were $43,574,000.

Profit Margin

Pulse Biosciences, Inc. (NASDAQ:PLSE): Profit margin
2014 0 -474.85K
2015 0 -2.81M
2016 0 -9.51M
2017 0 -25.56M
2018 0 -37.54M
2019 0 -45.98M
2020 0 -49.73M
2021 1.41M -63.16M -4454.16%
2022 700K -58.95M -8421.86%
2023 0 -42.21M

PLSE Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0700K1.41M0000000
Cost of revenue
1.20M11.94M1.96M665K666K665K665K665K00
Gross profit
-1.20M-11.24M-550K-665K-666K-665K-665K-665K00
Operating exp.
Research and development
27.79M20.83M28.64M26.44M24.96M17.25M9.64M5.98M2.57M44.57K
Selling and marketing
012.01M14.75M7.25M5.85M00000
Total operating expenses
43.57M46.81M62.46M49.96M47.95M37.96M25.81M9.58M4.46M514.28K
Operating income
-43.57M-58.05M-63.01M-49.96M-47.95M-37.96M-25.81M-9.58M-4.46M-308.57K
Other income (expenses), net
1.36M-448K-646K114K983K-28K247K68K0-396.00K
Income before tax
-42.21M-58.50M-63.66M-49.85M-46.97M-37.54M-25.56M-9.51M-4.46M-514.28K
Income tax expense
0448K-500K-114K-983K-28K-912K0-1.65M39.42K
Net income
-42.21M-58.95M-63.16M-49.73M-45.98M-37.54M-25.56M-9.51M-2.81M-474.85K
Earnings per share
Basic EPS
-0.88-1.74-2.26-2.14-2.22-2.2-1.73-0.86-0.37-0.19
Diluted EPS
-0.88-1.74-2.26-2.14-2.22-2.2-1.73-0.86-0.37-0.19
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source